Panagora Asset Management’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-67,723
| Closed | -$691K | – | 1199 |
|
2024
Q3 | $691K | Sell |
67,723
-63,830
| -49% | -$652K | ﹤0.01% | 836 |
|
2024
Q2 | $1.95M | Buy |
131,553
+10,787
| +9% | +$160K | 0.01% | 529 |
|
2024
Q1 | $1.65M | Sell |
120,766
-3,745
| -3% | -$51.1K | 0.01% | 630 |
|
2023
Q4 | $1.36M | Sell |
124,511
-21,765
| -15% | -$238K | 0.01% | 700 |
|
2023
Q3 | $1.6M | Buy |
146,276
+25,237
| +21% | +$276K | 0.01% | 606 |
|
2023
Q2 | $1.6M | Buy |
121,039
+4,305
| +4% | +$57K | 0.01% | 618 |
|
2023
Q1 | $1.59M | Buy |
116,734
+66,303
| +131% | +$902K | 0.01% | 652 |
|
2022
Q4 | $985K | Buy |
50,431
+14,076
| +39% | +$275K | 0.01% | 892 |
|
2022
Q3 | $693K | Buy |
36,355
+14,965
| +70% | +$285K | ﹤0.01% | 1019 |
|
2022
Q2 | $441K | Buy |
+21,390
| New | +$441K | ﹤0.01% | 1197 |
|